Phillip B. Donenberg
Overview
Phillip B. Donenberg received $2M in total compensation, including $159K in salary, at DepoMed in 2018. Phillip Donenberg also received an average of $700K at Diffusion Pharmaceuticals from 2014 to 2016 and an average of $576K at ANI Pharmaceuticals from 2006 to 2013.
- 2018
- 2016
- 2015
- 2014
- 2013
- 2012
- 2008
- 2007
- 2006
DepoMedFormer Senior Vice President and Chief Financial Officer
Diffusion PharmaceuticalsFormer Chief Financial Officer
Diffusion PharmaceuticalsFormer Chief Financial Officer
Diffusion PharmaceuticalsFormer Chief Financial Officer and Corporate Secretary
ANI PharmaceuticalsFormer Senior Vice President of Finance, Chief Financial Officer and Secretary
ANI PharmaceuticalsFormer Senior Vice President of Finance, Chief Financial Officer and Secretary
ANI PharmaceuticalsChief Financial Officer, Treasurer and Secretary
ANI PharmaceuticalsChief Financial Officer, Treasurer and Secretary
ANI PharmaceuticalsChief Financial Officer, Treasurer and Secretary
Source: SEC filings on April 8, 2019, May 12, 2017, June 10, 2016, April 11, 2014, and April 27, 2009.
Related executives
We found 36 more executives who work or worked at DepoMed, Diffusion Pharmaceuticals, andANI Pharmaceuticals.
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
Christopher Mutz
ANI Pharmaceuticals
Head of Rare Disease
Ori Gutwerg
ANI Pharmaceuticals
Senior Vice President, Generics
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Arthur Przybyl
ANI Pharmaceuticals